Mark W. Embrey

1.6k total citations
6 papers, 388 citations indexed

About

Mark W. Embrey is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Mark W. Embrey has authored 6 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Mark W. Embrey's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Biochemical and Molecular Research (2 papers). Mark W. Embrey is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Biochemical and Molecular Research (2 papers). Mark W. Embrey collaborates with scholars based in United States. Mark W. Embrey's co-authors include John Wai, Daria J. Hazuda, Marc Witmer, Abigail Wolfe, Thorsten E. Fisher, Lori J. Gabryelski, William A. Schleif, Peter J. Felock, Steven D. Young and Joseph P. Vacca and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Mark W. Embrey

5 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark W. Embrey United States	4	229	178	172	165	48	6	388
Gregory Moyer United States	4	206 0.9×	165 0.9×	244 1.4×	114 0.7×	50 1.0×	4	406
Takahisa Motomura Japan	7	253 1.1×	203 1.1×	161 0.9×	197 1.2×	58 1.2×	10	470
Thorsten E. Fisher United States	11	247 1.1×	186 1.0×	422 2.5×	219 1.3×	50 1.0×	15	643
Khalid Mekouar France	6	194 0.8×	146 0.8×	257 1.5×	171 1.0×	28 0.6×	6	472
Vandna Munshi United States	13	357 1.6×	278 1.6×	227 1.3×	208 1.3×	105 2.2×	14	592
R W Buckheit United States	10	221 1.0×	204 1.1×	191 1.1×	161 1.0×	82 1.7×	14	502
Valerie Fliakas-Boltz United States	9	352 1.5×	296 1.7×	146 0.8×	116 0.7×	88 1.8×	10	495
Yvonne Leonard United States	5	108 0.5×	86 0.5×	165 1.0×	105 0.6×	23 0.5×	5	298
Jay Brownell United States	8	229 1.0×	129 0.7×	160 0.9×	223 1.4×	70 1.5×	13	403
Woo‐Baeg Choi United States	12	208 0.9×	101 0.6×	288 1.7×	247 1.5×	77 1.6×	20	564

Countries citing papers authored by Mark W. Embrey

Since Specialization

Citations

This map shows the geographic impact of Mark W. Embrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Embrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Embrey more than expected).

Fields of papers citing papers by Mark W. Embrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Embrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Embrey. The network helps show where Mark W. Embrey may publish in the future.

Co-authorship network of co-authors of Mark W. Embrey

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Embrey. A scholar is included among the top collaborators of Mark W. Embrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Embrey. Mark W. Embrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Wai, John, Bo Young Kim, Thorsten E. Fisher, et al.. (2007). Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(20). 5595–5599. 21 indexed citations

2.

Embrey, Mark W., et al.. (2005). A Series of 5‐(5,6)‐Dihydrouracil Substituted 8‐Hydroxy‐[1,6]naphthyridine‐7‐carboxylic Acid 4‐Fluorobenzylamide Inhibitors of HIV‐1 Integrase and Viral Replication in Cells.. ChemInform. 37(2). 2 indexed citations

3.

Zhuang, Linghang, John Wai, Mark W. Embrey, et al.. (2003). Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells. Journal of Medicinal Chemistry. 46(4). 453–456. 219 indexed citations

4.

Shaw-Reid, Cathryn A., Vandna Munshi, Pia Graham, et al.. (2003). Inhibition of HIV-1 Ribonuclease H by a Novel Diketo Acid, 4-[5-(Benzoylamino)thien-2-yl]-2,4-dioxobutanoic Acid. Journal of Biological Chemistry. 278(5). 2777–2780. 135 indexed citations

5.

Embrey, Mark W., Thorsten E. Fisher, & John Wai. (1996). Synthesis of 3-Alkyl-6-bromo-4,5-E-hexenoate. Synthetic Communications. 26(18). 3431–3442.

6.

Wai, John, Thorsten E. Fisher, & Mark W. Embrey. (1995). An efficient synthesis of γ-alkylated E-olefin dipeptide isosteres. Tetrahedron Letters. 36(20). 3461–3464. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact